Periostosis and Crohn disease: value of methotrexate
Pierrugues, R.; Pansard, E.
Gastroenterologie Clinique et Biologique 19(11): 954-955
1995
ISSN/ISBN: 0399-8320 PMID: 8746059 Document Number: 451283
Document emailed within 1 workday
Related Documents
Arora, S.; Katkov, W.; Cooley, J.; Kemp, J.A.; Johnston, D.E.; Schapiro, R.H.; Podolsky, D. 1999: Methotrexate in Crohn's disease: results of a randomized, double-blind, placebo-controlled trial Hepato-Gastroenterology 46(27): 1724-1729Goebell, H.; Wienbeck, M.; Schomerus, H.; Malchow, H. 1990: Evaluation of the Crohn's Disease Activity Index (CDAI) and the Dutch Index for severity and activity of Crohn's disease. An analysis of the data from the European Cooperative Crohn's Disease Study Medizinische Klinik 85(10): 573-576
Auer, I.O.; Röder, A.; Mittelstaedt, A. 1985: Treatment of Crohn's disease using Colibiogen. Cellular reactions of the immune system in patients with Crohn's disease Fortschritte der Medizin 103(46): 1076-1080
Curry, S.L.; Blessing, J.A.; Disaia, P.J.; Soper, J.T.; Twiggs, L.B. 1989: A prospective randomized comparison of methotrexate, dactinomycin, and chlorambucil versus methotrexate, dactinomycin, cyclophosphamide, doxorubicin, melphalan, hydroxyurea, and vincristine in "poor prognosis" metastatic gestational trophoblastic disease: a Gynecologic Oncology Group study Obstetrics and Gynecology 73(3 Pt 1): 357-362
Etienne, A.M.; Dupuis, G. 2011: Maladie de Crohn et qualité de vie: des pistes d'intervention : Etudes cliniques récentes en thérapie comportementale et cognitive chez l'enfant, l'adolescent et l'adulte - Crohn's disease and quality of life: methods of intervention Perspectives Psychiatriques (Paris) 50(3): 246-255
Fiumicelli, A.; Bruni, L. 1993: Chronic idiopathic periostosis La Radiologia Medica 85(1-2): 103-107
Grégoire, A.; Combes, J.C.; Hornung, H.; Bensoussan, A. 1978: Recurrent multifocal periostosis in children: nosologic problems Pediatrie 33(5): 491-496
Elsner, J.; Kiehl, P.; Kapp, A.; Weiss, J. 1996: Erythema elevatum et diutinum bei Morbus Crohn : Klinischer Verlauf als Hinweis einer gemeinsamen Ätiologie ? - Erythema elevatum diutinum and Crohn's disease. Clinical course as evidence of a common etiology ? Hautarzt 47(9): 701-704
Ben Becher, S.; Essaddam, H.; Nahali, N.; Ben Hamadi, F.; Mouelhi, M.H.; Hammou, A.; Hadj Romdhane, L.; Ben Cheikh, M.; Boudhina, T.; Dargouth, M. 1991: Recurrent multifocal periostosis in children. Report of a familial form Annales de Pediatrie 38(5): 345-349
Kirsner, J.B. 1999: "Nonspecific" inflammatory bowel disease (ulcerative colitis and Crohn's disease) after 100 years--what next? Italian Journal of Gastroenterology and Hepatology 31(8): 651-658
Puleo, A.; Cappello, M.; Orlando, A.; Dardanoni, G.; Oliva, L.; Cottone, M. 1986: An evaluation of the laboratory parameters useful in the determination of disease activity in Crohn disease Recenti Progressi in Medicina 77(11): 511-514
Kruis, W.; Pfaff, G.; Lamerz, R.; Eisenburg, J. 1977: CEA blood level in patients with Crohn's disease with reference to localization, duration and severity of the disease Fortschritte der Medizin 95(47-48): 2795-2798
Akolkar, P.N.; Gulwani-Akolkar, B.; Heresbach, D.; Lin, X.Y.; Fisher, S.; Katz, S.; Silver, J. 1997: Differences in risk of Crohn's disease in offspring of mothers and fathers with inflammatory bowel disease American Journal of Gastroenterology 92(12): 2241-2244
Tarasova, G.V.; Shafranskiĭ, L.L.; Suleĭmanov, B.N. 1972: Systemic ossifying periostosis in a patient with osteogenic sarcoma metastasizing to the lungs Ortopediia Travmatologiia i Protezirovanie 33(9): 81-82
Doe, W.F.; Booth, C.C.; Brown, D.L. 1973: Evidence for complement-binding immune complexes in adult coeliac disease, Crohn's disease, and ulcerative colitis Lancet 1(7800): 402-403
Bamba, S.; Tsujikawa, T.; Ban, H.; Imaeda, H.; Inatomi, O.; Nishida, A.; Sasaki, M.; Andoh, A.; Fujiyama, Y. 2014: Predicting Mucosal Healing in Crohn's Disease Using Practical Clinical Indices with Regard to the Location of Active Disease Hepato-Gastroenterology 61(131): 689-696
García López, S. 2008: Inflammatory bowel disease. If a patient with Crohn's disease remains in remission for 4 years with azathioprine (or mercaptopurine), should the drug be withdrawn? Gastroenterologia y Hepatologia 31(10): 704-705
Talstad, I.; Gjone, E. 1976: The disease activity of ulcerative colitis and Crohn's disease Scandinavian Journal of Gastroenterology 11(4): 403-408
Houman, M.H.; Doghri, A.; Boubaker, J.; Kchir, M.N.; Mahdhaoui, A.; Filali, A.; Miled, M. 1996: Takayasu disease in Crohn disease: an exceptional association Annales de Gastroenterologie et d'Hepatologie 31(6): 337-340
Johnson, W.R.; Hughes, E.S.; McDermott, F.T.; Polglase, A.L.; Pihl, E.A. 1982: Inflammatory bowel disease--where are we? A review of ulcerative colitis and Crohn's disease, highlighting the problems of aetiology, epidemiology, clinical factors and management Medical Journal of Australia 1(5): 226-229